In last trading session, Allarity Therapeutics Inc (NASDAQ:ALLR) saw 1.56 million shares changing hands with its beta currently measuring -0.28. Company’s recent per share price level of $1.01 trading at $0.02 or 1.93% at ring of the bell on the day assigns it a market valuation of $17.18M. That closing price of ALLR’s stock is at a discount of -10177.23% from its 52-week high price of $103.80 and is indicating a premium of 39.6% from its 52-week low price of $0.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.33 million shares which gives us an average trading volume of 2.39 million if we extend that period to 3-months.
For Allarity Therapeutics Inc (ALLR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Upright in the green during last session for gaining 1.93%, in the last five days ALLR remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $1.01 price level, adding 8.18% to its value on the day. Allarity Therapeutics Inc’s shares saw a change of -13.68% in year-to-date performance and have moved 20.02% in past 5-day. Allarity Therapeutics Inc (NASDAQ:ALLR) showed a performance of 1.00% in past 30-days. Number of shares sold short was 1.2 million shares which calculate 0.39 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 84.72% during past 5 years.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Insiders are in possession of 4.38% of company’s total shares while institution are holding 0.61 percent of that, with stock having share float percentage of 0.64%. Investors also watch the number of corporate investors in a company very closely, which is 0.61% institutions for Allarity Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 7.11 shares of worth $7185.0 or 0.04% of the total outstanding shares. The later fund manager was in possession of 3.3 shares on Feb 28, 2025 , making its stake of worth around $3328.0 in the company or a holder of 0.02% of company’s stock.
